Overnight urine growth hormone, cortisol and adenosine 3' 5' cyclic monophosphate excretion in children with chronic asthma treated with inhaled beclomethasone dipropionate.
Overnight urine samples were obtained from 34 asthmatic children, 24 of whom were receiving inhaled beclomethasone dipropionate (BDP), and 30 controls. The urine volume of the children receiving inhaled steroids was significantly greater than that of the other asthmatic children and of the controls (P < 0.05). Urine growth hormone was within the normal range for all of the subjects and there was no demonstrable relationship between urine growth hormone and height or height standard deviation score. Urine steroid output was significantly reduced in the BDP receiving group when the results were expressed in U l-1 but there was no difference between the groups when the results were expressed per specimen. Urine adenosine 3' 5' cyclic monophosphate (cAMP) results were similar for all groups. We conclude that use of BDP increases overnight urine volume but, in our study, does not appear to influence the output of urine cortisol. Urine free cortisol measurements may not be a very sensitive tool for the detection of small changes in endogenous steroid production. The use of BDP does not adversely affect the output of urine growth hormone.
Zeitlin
S
S
Department of Child Health, Southampton General Hospital, U.K.
Wood
P
P
Evans
A
A
Radford
M
M
D000280:Administration, Inhalation; D001249:Asthma / Q000188:drug therapy / Q000652:urine*; D001507:Beclomethasone / Q000008:administration & dosage*; D002648:Child; D000242:Cyclic AMP / Q000652:urine*; D005260:Female; D013006:Growth Hormone / Q000652:urine*; D006801:Humans; D006854:Hydrocortisone / Q000652:urine*; D008297:Male; D014556:Urine
D013006:Growth Hormone; D000242:Cyclic AMP; D001507:Beclomethasone; D006854:Hydrocortisone